X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS WYETH LTD DR. DATSONS LABS/
WYETH LTD
 
P/E (TTM) x -10.9 27.7 - View Chart
P/BV x 0.2 5.3 3.0% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 DR. DATSONS LABS   WYETH LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
WYETH LTD
Mar-13
DR. DATSONS LABS/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1261,044 12.0%   
Low Rs31818 3.8%   
Sales per share (Unadj.) Rs133.0298.6 44.5%  
Earnings per share (Unadj.) Rs0.257.2 0.3%  
Cash flow per share (Unadj.) Rs6.658.4 11.3%  
Dividends per share (Unadj.) Rs017.00 0.0%  
Dividend yield (eoy) %01.8 0.0%  
Book value per share (Unadj.) Rs128.8249.5 51.6%  
Shares outstanding (eoy) m31.6622.72 139.3%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.1 18.9%   
Avg P/E ratio x516.116.3 3,172.6%  
P/CF ratio (eoy) x11.815.9 74.3%  
Price / Book Value ratio x0.63.7 16.3%  
Dividend payout %029.7 0.0%   
Avg Mkt Cap Rs m2,47721,157 11.7%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m56400 14.0%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m4,2116,783 62.1%  
Other income Rs m79353 22.3%   
Total revenues Rs m4,2897,136 60.1%   
Gross profit Rs m5691,617 35.2%  
Depreciation Rs m20427 768.4%   
Interest Rs m4306 7,821.8%   
Profit before tax Rs m131,938 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m6632 1.0%   
Profit after tax Rs m51,301 0.4%  
Gross profit margin %13.523.8 56.6%  
Effective tax rate %48.032.6 147.2%   
Net profit margin %0.119.2 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,8526,984 98.1%   
Current liabilities Rs m6,7112,056 326.4%   
Net working cap to sales %3.372.6 4.6%  
Current ratio x1.03.4 30.1%  
Inventory Days Days16199 162.0%  
Debtors Days Days31824 1,330.4%  
Net fixed assets Rs m3,673244 1,503.5%   
Share capital Rs m317227 139.3%   
"Free" reserves Rs m3,7615,441 69.1%   
Net worth Rs m4,0785,668 71.9%   
Long term debt Rs m1,67125 6,683.2%   
Total assets Rs m12,6337,901 159.9%  
Interest coverage x1.0353.3 0.3%   
Debt to equity ratio x0.40 9,290.1%  
Sales to assets ratio x0.30.9 38.8%   
Return on assets %3.416.5 20.8%  
Return on equity %0.122.9 0.5%  
Return on capital %7.734.0 22.5%  
Exports to sales %22.90.2 10,493.7%   
Imports to sales %14.336.3 39.3%   
Exports (fob) Rs m96415 6,513.5%   
Imports (cif) Rs m6022,465 24.4%   
Fx inflow Rs m96415 6,342.1%   
Fx outflow Rs m6072,677 22.7%   
Net fx Rs m357-2,662 -13.4%   
CASH FLOW
From Operations Rs m1,345923 145.7%  
From Investments Rs m-2,256317 -711.8%  
From Financial Activity Rs m-1,200-481 249.4%  
Net Cashflow Rs m-2,111759 -278.1%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 1.4 7.2 18.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 30.4 309.5%  
Shareholders   20,807 21,978 94.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SHASUN PHARMA  CIPLA  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - CIPLA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS